Medications

FDA approves Roche drug for non-small cell lung cancer

The U.S. Food and Drug Administration has approved Roche's Tecentriq as adjuvant treatment following surgery and platinum-based chemotherapy, for adults with Stage II-IIIA non-small cell lung cancer, as determined by an FDA-approved ...

Oncology & Cancer

Targeting a rare secondary cancer in children

It's one of the most heartbreaking things Adam Green, MD, sees as a pediatric oncologist: children who beat their cancer, only to see an incurable brain tumor arise five years later.

Oncology & Cancer

Scientists obtain real-time look at how cancers evolve

From amoebas to zebras, all living things evolve. They change over time as pressures from the environment cause individuals with certain traits to become more common in a population while those with other traits become less ...

Medical research

Researchers discover protein that promotes chemotherapy resistance

Chemotherapy is a drug treatment that uses powerful chemicals to kill fast-growing cancer cells in the body. It is a systemic treatment where drugs travel throughout the body and destroy cancer cells that have spread (metastasized) ...

page 8 from 40